Roaring Fork Family Physicians, P.c. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1340 Highway 133, Carbondale, CO 81623 Phone: 970-963-3350 Fax: 970-963-2958 |
Roaring Fork Family Practice Family Medicine Medicare: Medicare Enrolled Practice Location: 978 Euclid Avenue, Carbondale, CO 81623 Phone: 970-963-3350 |
Valley View Hospital Association Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1200 Village Lane, Carbondale, CO 81623 Phone: 970-384-6707 Fax: 970-384-8128 |
Mountain Family Health Centers Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Not Enrolled in Medicare Practice Location: 2270 Highway 133, Carbondale, CO 81623 Phone: 970-945-2840 Fax: 970-945-2893 |
Valley View Hospital Association Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1200 Village Rd, Carbondale, CO 81623 Phone: 970-963-3350 Fax: 970-963-2958 |
News Archive
If genes form the body's blueprint, then the layer of epigenetics decides which parts of the plan get built. Unfortunately, many cancers hijack epigenetics to modulate the expression of genes, thus promoting cancer growth and survival.
Biogen Idec today announced enrollment of the first patient in a multicenter Phase II clinical trial designed to evaluate its investigational oral therapy BG-12 (dimethyl fumarate) in combination with commonly used first-line treatments in patients with relapsing-remitting multiple sclerosis (RRMS).
Scientists at the Johns Hopkins Kimmel Cancer Center say they have evidence that cancer stem cells for multiple myeloma share many properties with normal stem cells and have multiple ways of resisting chemotherapy and other treatments.
In a study of more than 68,000 infants published in the New England Journal of Medicine, the investigational vaccine Rotateq demonstrated that it can safely prevent 98 percent of severe cases of viral diarrhea and vomiting that account for 2 million hospital visits and 500,000 pediatric deaths each year worldwide.
Prostate cancer tumors from African American men had higher frequencies of certain genetic alterations that may be associated with aggressive disease, compared with prostate cancer tumors from white men.
› Verified 7 days ago